Is oral dydrogesterone equivalent to vaginal micronized progesterone for luteal phase support in women receiving oocyte donation?

Margaux Lorillon, Geoffroy Robin, Laura Keller, Emeline Cailliau, Clémence Delcourt, Virginie Simon, Christine Decanter, Sophie Catteau-Jonard · 2024

Read Is oral dydrogesterone equivalent to vaginal micronized progesterone for luteal phase support in women receiving oocyte donation? by Margaux Lorillon, Geoffroy Robin, Laura Keller, Emeline Cailliau, Clémence Delcourt, Virginie Simon, Christine Decanter, Sophie Catteau-Jonard (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11619143.txt.

Description

Margaux Lorillon and seven co-authors published a fertility study in twenty twenty-four comparing two hormone supports for women receiving donated eggs. After embryo transfer, progesterone support comes either as an oral drug or as vaginal capsules, alongside weekly injections. Patients prefer swallowing a pill, but proof of equal results was needed.

The Lille hospital team reviewed three hundred seventy-two donation cycles from twenty eighteen to twenty twenty-two. Clinical pregnancy rates were thirty-six point seven percent with vaginal support and thirty point three percent with oral, a difference that vanished after adjustment. Ongoing pregnancy, miscarriage, and live birth rates also matched. The oral route appears a fair substitute in this setting.

Catalog record

CREATORMargaux Lorillon, Geoffroy Robin, Laura Keller, Emeline Cailliau, Clémence Delcourt, Virginie Simon, Christine Decanter, Sophie Catteau-Jonard
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11619143

Browse the full library · About the Tower of Babel